Mark Rush
Advertisement
Mark is a partner and associate in Kirkpatrick & Lockhart, www.kl.com, a national law firm experienced in complex commercial litigation, intellectual property enforcement, and regulatory practice
Articles by Mark Rush
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz
2
The Battle to Own the GLP-1 Patient Journey
3
FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A
4
FDA Approves Kerendia for Adults with Chronic Kidney Disease and Type 1 Diabetes
5
